A detailed history of Gries Financial LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Gries Financial LLC holds 1,828 shares of LLY stock, worth $1.67 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
1,828
Previous 485 276.91%
Holding current value
$1.67 Million
Previous $282,000 404.26%
% of portfolio
0.27%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $795,324 - $1.06 Million
1,343 Added 276.91%
1,828 $1.42 Million
Q4 2023

Feb 13, 2024

SELL
$525.19 - $619.13 $59,871 - $70,580
-114 Reduced 19.03%
485 $282,000
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $39,123 - $53,936
-90 Reduced 13.06%
599 $321,000
Q1 2023

Jun 21, 2023

BUY
$310.63 - $364.82 $8,387 - $9,850
27 Added 4.08%
689 $236,000
Q4 2022

Jan 10, 2023

BUY
$321.55 - $374.67 $212,866 - $248,031
662 New
662 $242,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $869B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Gries Financial LLC Portfolio

Follow Gries Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gries Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gries Financial LLC with notifications on news.